Advances in pharmacogenomics of antiretrovirals: an update.

Advances in pharmacogenomics of antiretrovirals: an update. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Advances in pharmacogenomics of antiretrovirals: an update. Abstract Text:

Qing Ma,Dan Brazeau,Alan Forrest,Gene D Morse,Qing Ma,Dan Brazeau,Alan Forrest,Gene D Morse,

Recent developments in the pharmacogenomics of antiretroviral drugs provide new prospects for predicting the efficacy of treatment and potential adverse effects. HIV/AIDS is a serious but treatable infectious disease, yet current treatment is limited by high rates of adverse drug reactions and development of resistance due to suboptimal drug concentrations in a significant proportion of patients. Antiretroviral therapy is especially suitable for pharmacogenomic investigation as both drug exposure and treatment response can be quantified and certain adverse effects can be assessed with validated measures. Additionally, there is increasing knowledge of the pharmacokinetics and dynamics of antiretroviral drugs, and some candidate genes implicated in the metabolism, transport and adverse effects have been identified. However, recent studies of the association of particular genes and their genetic variants with HIV management and adverse drug reactions have not provided unifying conclusions. This article reviews the most recently published work and summarizes the state of research in this area. Future directions for research and the application of this technology to the clinical practice of individualizing treatment for HIV management are discussed.

Advances in pharmacogenomics of antiretrovirals: an update. Publishing Authors By Initials

Q Ma,D Brazeau,A Forrest,GD Morse,Q Ma,D Brazeau,A Forrest,GD Morse,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Advances in pharmacogenomics of antiretrovirals: an update. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Pharmacogenomics

VOLUME: 8

Page Numbers: 1169-78

Journal Abbreviation: Pharmacogenomics

ISSN: 1462-2416

DAY: 10

MONTH: Sep

YEAR: 2007

Advances in pharmacogenomics of antiretrovirals: an update. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100897350

Advances in pharmacogenomics of antiretrovirals: an update. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Advances in pharmacogenomics of antiretrovirals: an update. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Advances in pharmacogenomics of antiretrovirals: an update.

AFFILIATION: Pharmacotherapy Research Center, University at Buffalo, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY 14260, USA. emorse@buffalo.edu; qingma@buffalo.edu.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Pharmacogenomics

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Advances in pharmacogenomics of antiretrovirals: an update Related Publications

• A dinoflagellate AAA family member rescues a conditional yeast G1/S phase cyclin mutant through increased CLB5 accumulation.
• Advances in pharmacogenomics of antiretrovirals: an update.
• Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.
• Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring.
• Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension.
• Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users.
• Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks.
• Determination of lopinavir cerebral spinal fluid and plasma ultrafiltrate concentrations by liquid chromatography coupled to tandem mass spectrometry.
• Direct selection of RNA beacon aptamers.
• Drug interactions between proton pump inhibitors and antiretroviral drugs.
• Duplicate publication.
• Effects of pyriproxyfen on California red scale (Hemiptera: Diaspididae) development and reproduction.
• Functional deficiency in IL-7 caused by an N-ethyl-N-nitrosourea-induced point mutation.
• Genome-wide analysis of transcriptional dependence and probable target sites for Abf1 and Rap1 in Saccharomyces cerevisiae.
• Global infectious disease surveillance and health intelligence.
• Global preparedness for public health emergencies.
• HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries.
• Hierarchical assembly of the siliceous skeletal lattice of the hexactinellid sponge Euplectella aspergillum.
• High resolution Fourier-domain optical coherence tomography of retinal angiomatous proliferation.
• Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application.
• Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV.
• Pandemic influenza: studying the lessons of history.
• Rotationally resolved spectroscopy of jet-cooled NbMo.
• Simulations of dynamics and viscoelasticity in highly entangled solutions of semiflexible rods.
• Technology evaluation: BLP-25, Biomira Inc.
• The US pandemic influenza implementation plan at six months.
• Toxicity of systemic neonicotinoid insecticides to avocado thrips in nursery avocado trees.
• Transcription factor access to promoter elements.
• Use of the finite element method to assess impact of current on forearm and wrist during an electrical accident.
• Wide dynamic range germanium detector for perturbation crystallography.